Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway

by Jonathan Barratt, Jonathan Barratt, Ilene Weitz
Published 2021-09-01

Multimethods study comparing the experiences of medical clinical academics with nurses, midwives and allied health professionals pursuing a clinical academic career

by Jonathan Barratt
Published 2021-04-01

The Non-Coding RNA Landscape in IgA Nephropathy—Where Are We in 2021?

by Izabella Z. A. Pawluczyk, Haresh Selvaskandan, Jonathan Barratt
Published 2021-05-01

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy

by Chee Kay Cheung, Arun Rajasekaran, Jonathan Barratt, Dana V. Rizk
Published 2021-06-01

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management

by Haresh Selvaskandan, Sufang Shi, Sara Twaij, Chee Kay Cheung, Jonathan Barratt
Published 2020-10-01

New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy

by Katrin Scionti, Karen Molyneux, Haresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
Published 2021-10-01

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.

by Min Jeong Kim, Stefan Schaub, Karen Molyneux, Michael T Koller, Susanne Stampf, Jonathan Barratt
Published 2016-01-01

Why Target the Gut to Treat IgA Nephropathy?

by Jonathan Barratt, Brad H. Rovin, Daniel Cattran, Jürgen Floege, Richard Lafayette, Vladimir Tesar, Hernán Trimarchi, Hong Zhang
Published 2020-10-01

Long-Term Therapeutic Plasma Exchange to Prevent End-Stage Kidney Disease in Adult Severe Resistant Henoch-Schonlein Purpura Nephritis

by Patrick Hamilton, Olumide Ogundare, Ammar Raza, Arvind Ponnusamy, Julie Gorton, Hana Alachkar, Jamil Choudhury, Jonathan Barratt, Philip A. Kalra
Published 2015-01-01

The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney Disease

by Emma L. Watson, Joao L. Viana, Joao L. Viana, David Wimbury, Naomi Martin, Naomi Martin, Neil J. Greening, Jonathan Barratt, Alice C. Smith, Alice C. Smith
Published 2017-07-01

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank

by Kittiya Sukcharoen, Seth A. Sharp, Nicholas J. Thomas, Robert A. Kimmitt, Jamie Harrison, Coralie Bingham, Monika Mozere, Michael N. Weedon, Jessica Tyrrell, Jonathan Barratt, Daniel P. Gale, Richard A. Oram
Published 2020-10-01

Epidemiology, baseline characteristics and risk of progression in the first South-Asian prospective longitudinal observational IgA nephropathy cohort

by Suceena Alexander, Santosh Varughese, Rajanbabu Franklin, Sanjeet Roy, Grace Rebekah, Vinoi George David, Anjali Mohapatra, Anna T. Valson, Shibu Jacob, Pradeep Mathew Koshy, Gautham Rajan, Mohamed R. Daha, John Feehally, Jonathan Barratt, George T. John
Published 2021-02-01

Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk prof...

by Suceena Alexander, George T. John, Anila Korula, T. S. Vijayakumar, Vinoi George David, Anjali Mohapatra, Anna T. Valson, Shibu Jacob, Pradeep Mathew Koshy, Gautam Rajan, Elenjickal Elias John, Smita Mary Matthai, L. Jeyaseelan, Babu Ponnusamy, Terence Cook, Charles Pusey, Mohamed R. Daha, John Feehally, Jonathan Barratt, Santosh Varughese
Published 2018-07-01